Sameet Kanade

Sameet Kanade has a diverse work experience spanning various roles and industries. Sameet is currently serving as the CEO at Steep Hill since February 2022. Before that, they were the CEO of Molecular Science Corp., a subsidiary of Steep Hill Inc, from November 2021 to September 2022. Sameet also co-founded Anahit International Corp. in December 2018 and held the position of Co-Founder until December 2020. Prior to that, they served as the Co-Founder & CFO of Molecular Science Corp. from October 2016 to December 2018. Additionally, Sameet served as a Member of the Board of Directors at Reliq Health Technologies Inc. from August 2015 to January 2016. Sameet'searlier experience includes roles at Jacob Securities Inc., where they worked as Director of Investment Banking (Tech & Diversified) from January 2014 to December 2015 and as an Equity Research Analyst (Tech & Diversified) from March 2013 to December 2013.

Sameet Kanade has a Master of Business Administration degree in Finance & Strategy from the University of Toronto - Rotman School of Management, which they completed in 2006. Sameet also holds a Chartered Accountant ACA certification from The Institute of Chartered Accountants of India. The specific years of study for their Chartered Accountant degree are not provided.